Quantcast

Latest Ribbon symbolism Stories

2014-03-26 16:25:02

TORONTO, March 26, 2014 /CNW/ - The most comprehensive review of the performance of Canada's cancer control systems reveals that some older Canadians with colon, lung or breast cancer are not receiving guideline-recommended radiation and chemotherapy at the same rate as younger patients with these cancers. This age-related disparity may be explained by a number of factors. For example, older people are more likely to have other acute and or chronic health problems, which could...

2014-03-26 16:11:46

A breast cancer therapy that blocks estrogen synthesis to activate cancer-killing genes sometimes loses its effectiveness because the cancer takes over epigenetic mechanisms, including permanent DNA modifications in the patient's tumor, once again allowing tumor growth, according to an international team headed by the University of Pittsburgh Cancer Institute (UPCI). The finding warrants research into adding drugs that could prevent the cancer from hijacking patients' repressive gene...

Peaches Could Inhibit Breast Cancer Spread
2014-03-26 12:41:00

Lee Rannals for redOrbit.com - Your Universe Online According to a study published in the Journal of Nutritional Biochemistry, peach extract could slow down the growth and spread of breast cancer. Scientists working with mice discovered that a mixture of phenolic compounds found in peach extract inhibits breast cancer metastasis. The team said that the compounds could be a new addition to therapies to help reduce the risk of metastasis, which is the primary killer in breast and many...

Gregory Tsongalis PhD
2014-03-26 03:00:14

Norris Cotton Cancer Center, Dartmouth College Dartmouth researchers at its Norris Cotton Cancer Center have compiled a review of the role that information gathered through genetic testing plays in the diagnosis and treatment of breast cancer. The paper entitled "Personalized Therapy for Breast Cancer" was accepted on March 17, 2014, for publication in Clinical Genetics. The paper discusses targeted therapies, new biomarkers, and the quality of commercially available testing methods....

2014-03-25 12:29:41

Perjeta and Kadcyla are Reshaping the Treatment Algorithm for Patients with HER2-Positive Breast Cancer, According to Findings from Decision Resources Group BURLINGTON, Mass., March 25, 2014 /PRNewswire/ -- Decision Resources Group finds that efficacy more than any other factors drives oncologists' prescribing of targeted therapies for breast cancer and, according to the majority of surveyed oncologists, the escalating overall cost of drug treatment for breast cancer has little or no impact...

2014-03-25 08:29:51

Inspired to save the lives of Coachella Valley cancer patients, BIGHORN Behind a Miracle (BAM) reached an exciting milestone of raising $1 million at their kick-off party, A Night of Miracles, for BIGHORN BAM Week that also includes a Caddy Auction and Golf Tournament. PALM DESERT, Calif., March 25, 2014 /PRNewswire/ -- BIGHORN BAM Founder Selby Dunham took her breast cancer survivor story and decided to give back to the hospital and community she loves so much. In the past 7...

2014-03-24 20:22:55

DUBLIN, March 25, 2014 /PRNewswire/ -- Research and Markets ( http://www.researchandmarkets.com/research/czqbv2/investigation) has announced the addition of the "Investigation Report on China Trastuzumab Market, 2009-2018" [http://www.researchandmarkets.com/research/czqbv2/investigation ] report to their offering. (Logo: http://photos.prnewswire.com/prnh/20130307/600769 ) Trastuzumab is a monoclonal antibody that interferes with the HER2/neu receptor. Its main...

2014-03-22 23:04:05

Pretty In Pink Foundation achieves business milestone while providing hope and healing to underinsured and uninsured North Carolinians diagnosed with breast cancer Raleigh, NC (PRWEB) March 22, 2014 Headquartered in Raleigh, North Carolina under the leadership of its Founder Dr. Lisa Tolnitch, Pretty In Pink Foundation (http://www.prettyinpinkfoundation.org) proudly celebrates ten years of serving North Carolinian women and men diagnosed with breast cancer who are unable to pay for...

Mammograms Needed More Often For One-Third Of Women
2014-03-22 07:07:50

April Flowers for redOrbit.com - Your Universe Online While three-year intervals between mammograms are appropriate for most women, a new study from the UK NHS Breast Screening Program has found that one-third of women are at a higher risk of developing cancer. These women, according to the report delivered this week at the 9th European Breast Cancer Conference (EBCC-9), might benefit from more frequent mammograms. Professor Gareth Evans, from the University of Manchester, reported that...

2014-03-20 23:22:02

Entinostat is being investigated in patients with advanced hormone receptor-positive breast cancer by the ECOG-ACRIN Cancer Research Group in its latest trial, E2112. Philadelphia, PA, and Waltham, MA (PRWEB) March 20, 2014 The ECOG-ACRIN Cancer Research Group (ECOG-ACRIN) and Syndax Pharmaceuticals, Inc., announced today that patient recruitment has begun for E2112, a randomized phase III clinical trial of Syndax’s entinostat in treatment of patients with advanced breast cancer. The...


Word of the Day
monteith
  • A large punch-bowl of the eighteenth century, usually of silver and with a movable rim, and decorated with flutings and a scalloped edge. It was also used for cooling and carrying wine-glasses.
  • A kind of cotton handkerchief having white spots on a colored ground, the spots being produced by a chemical which discharges the color.
This word is possibly named after Monteith (Monteigh), 'an eccentric 17th-century Scotsman who wore a cloak scalloped at the hem.'
Related